Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FCNAX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for XOLAIR 75 mg/0.5 mL syringes on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a specific pharmaceutical procurement executed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis in the federal pharmaceutical supply chain.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. This delivery order for XOLAIR, a biologic medication, reflects DMS Pharmaceutical Group's established role as a critical supplier within the SPE2DB program, which enables DLA to procure comprehensive pharmaceutical products supporting military health systems globally. No subcontractors are identified in this award.
Quick answers
Who was awarded contract SPE2DB25FCNAX?
SPE2DB25FCNAX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FCNAX worth?
The government has obligated $1,547 on SPE2DB25FCNAX.
Is contract SPE2DB25FCNAX an order under another contract?
Yes. SPE2DB25FCNAX is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAX competed?
The extent of competition for SPE2DB25FCNAX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award